Disclosure Policy
Harvard Medical School has long held the standard that its continuing medical education courses be free of commercial bias.
In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education, course planners, speakers, and content reviewers have been asked to disclose any relevant relationship they, or their spouse or partner, have to companies producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.
Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide the course director and participants with information that might be of potential importance to their evaluation of a given presentation.
Disclosure Statement
The following planners, speakers, and content reviewers, on behalf of themselves and their spouse or partner, have reported financial relationships with an entity producing, marketing, re-selling, or distributing health care goods or services (relevant to the content of the activity) consumed by, or used on, patients:
Name: Ajay K. Singh, MBBS, FCRP (UK), MBA
Role: Course Planner and Faculty
Company: GlaxoSmithKline
Relationship: Research
Name: Louis Pasquale, MD
Role: Committee on Proposal Review Member
Company: Bausch + Lomb
Relationship: Paid Consultant
Company: Novartis
Relationship: Non-Paid Consultant
Company: Allergan
Relationship: Speaker
Company: NEI
Relationship: Grant
Company: Merck
Relationship: Unrestricted Grant
All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.